Galectin Therapeutics shares owned by Sontag Advisory
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sontag Advisory
from 13F filings
Historical chart of Sontag Advisory investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Sontag Advisory
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $305k | 184k | 1.66 |
| 2023-09-30 | $353k | 184k | 1.92 |
| 2023-06-30 | $265k | 184k | 1.44 |
| 2023-03-31 | $386k | 184k | 2.10 |
| 2022-09-30 | $28k | 17k | 1.61 |
| 2022-06-30 | $23k | 17k | 1.33 |
| 2022-03-31 | $28k | 17k | 1.61 |
| 2021-12-31 | $29k | 14k | 2.09 |
| 2021-09-30 | $54k | 14k | 3.90 |
| 2021-06-30 | $44k | 14k | 3.18 |
| 2021-03-31 | $30k | 14k | 2.17 |
| 2020-12-31 | $31k | 14k | 2.24 |
| 2020-09-30 | $37k | 14k | 2.67 |
| 2020-06-30 | $42k | 14k | 3.03 |
| 2020-03-31 | $27k | 14k | 1.95 |
| 2019-12-31 | $40k | 14k | 2.89 |
| 2019-09-30 | $51k | 14k | 3.68 |